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Abstract
To evaluate anticancer and antioxidant potentials of activity of methanol extract of Tephrosia calophylla. The methanol extract of
Tephrosia calophylla was prepared and tested for in vitro anticancer activity by using human MCF 7, HCT-116, HEP-G2, A-549
cancer and vero normal cell lines. The antioxidant activity for the extract was evaluated by Superoxide scavenging, Lipid perox-
idation and DPPH methods. IC50 values of extracts were parameters in both studies. The results of the study have shown that
methanol extract of Tephrosia calophylla has shown significant IC50 values against MCF 7, HCT-116 and A-549 cell lines which
shows its anticancer potentials but inhibitory effect of methanol extract against HEP-G2 and vero cell lines was not significant.
The results also suggest that the methanol extract of Tephrosia calophylla has significant antioxidant properties against Super-
oxide scavenging, Lipid peroxidation and DPPH methods.The present study shows anticancer potentials of methanol extract of
Tephrosia calophylla against MCF 7, HCT-116 and A-549 cell lines.
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Introduction
Cancer is pathological condition which has been characterized
by excessive proliferation of abnormal cells and always been
a major threat to developing and developed countries [1]. It is
most common and serious complication as it slaughters societies
more than malaria, tuberculosis, and HIV [2]. About 12.5% of
deaths worldwide reported every year are due to cancer. Among
15.6 million cases of cancer were reported 2016, 45% were from
developed and the remaining 55% were from developing coun-
tries [3]. Breast, lung, liver and colorectal cancers are most com-
mon cancers in the world [4] Moreover, the incidence of this dis-
ease has increased steadily in recent years [5]. Despite advances
in medicinal field over the past few decades, the mortality rate of
patients diagnosed with cancers remains more than 60% mainly
*Correspondence: rameshcology80@gmail.com
1Department of Pharmacology, East West College of Pharmacy
Full list of author information is available at the end of the article.
due to ineffectiveness and toxicity of presently available cyto-
toxic drugs [6]. Chemotherapy of cancer usually involves lots of
adverse effects like alopecia, vomiting, bone marrow deression,
diarrhoea, anorexia, imuune suppression, reproductive toxicity
and etc. Hence till now there is no truly satisfactory anticancer
agent for the effective treatment of cancers with the least side
effects [7, 8].
Medicinal plants have been used since ancient time in
Ayurveda and other traditional medicine system and their util-
ity has been increasing day by day throughout world. Natural
compounds obtained from herbs are considerably safe and ef-
fective than synthetic compounds. Moreover, the problem of
development of drug less compared to synthetic drugs. is also
reduced. The herbal drugs comprise a major source of anticancer
medicine due to presence of various phyto-constituents such as
vincristine, vinblastine, taxanes, camptothecines and in devel-
oped countries and developing countries [9]. The free radicals
are the main agents which induces mutation by damaging cellu-
lar DNA ultimately leads to development of cancers in the body.
Hence much attention has been given on the development of
anticancer agents that possess antioxidant property due to their
free radical scavenging potential which plays an important role
in protection of DNA free radical mediated damage [10].
The Tephrosia is a genus of plant which is of Indian and
several species of Tephrosia are medicinally important and
have used in ayurveda for the treatment of ailments [11]. The
Tephrosia calophylla belongs to this genus frequently used as
traditional and folklore medicine for the management various
health complications such as ulcer, diabetes, urinary disorders,
liver diseases and cancer [12]. Though this plant used essen-
tially in traditional medicine for cancer, it has lack of scientific
evidence. Hence, it was necessary to provide a clear background
proof for the beneficial property of the plant in cancer. In this at-
tempt, the study had been conducted to determine in vitro antiox-




The areal parts of plant Tephrosia villosa have been collected
from the surroundings of Sri Venkateshwara University, Tiru-
pati, India and dried under shade. The plant material was iden-
tified and authenticated by Dr. Madhava Chetty Asst.Prof., De-
partment of Botany Sri Venkateshwara university, Tirupati and
specimen herbarium was preserved at institute herbarium li-
brary. The aerial parts of plant were separated from other parts,
washed, cleaned and dried under shade for further use.
Preparation of extract
The shade dried plant material was pulverised into powder and
passed through sieve No. 22 mesh. About 350 g (appx.) of coarse
powder was subjected to successive solvent extraction using
petroleum ether and methanol in soxhlet’s apparatus [13]
Preliminary phytochemical investigation
The preliminary phytochemical investigation for the methanolic
extract of Tephrosia villosa had been conducted as per procedure
prescribed by Khandelwal [14].
Drugs and chemicals
All reagents and chemicals used in the study were obtained
commercially and were of analytical grade. The standard drugs
tamoxifen and paclitaxel were obtained as gift samples from
Strides laboratories, Bangalore.
Evaluation of antioxidant property
The evaluation of antioxidant activity of ethanolic extract of
Tephrosia calophylla was carried out by the following two meth-
ods:
Lipid peroxidation method
Lipid peroxidation inhibition was estimated by the formation of
colored product in the reaction mixture. The assay mixture con-
tained the ethanolic extract in various concentrations, to which
were added 0.1 ml of potassium chloride (30 mM), 0.1 ml of
ascorbic acid (0.06 mm) and 0.1 ml of ammonium ferrous sul-
phate (0.16 mM) in succession. Later the reaction mixture was
treated with 0.2 ml of sodium dodecyl sulphate (8.1%), 1.5 ml
of thiobarbituric acid (0.8%) and 1.5 ml of 20 % acetic acid
(pH 3.5) and then 5 ml of 15:1 v/v butanol-pyridine mixture was
added. The absorbance of the organic layer containing the thio-
barbituric acid reactive substances (TBARS) was measured at
532 nm [15].
DPPH radical scavenging activity
The free radical scavenging activity was measured in terms of
hydrogen donating or radical scavenging ability, using the stable
radical, DPPH. About 0.1 mM solution of DPPH in methanol
was prepared and 1 ml of this solution was added to 3 ml of
the different concentration of ethanolic extract (50-400 µg/ml)
in different test tubes. The mixture was shaken and allowed to
stand at room temperature for 30 min and the absorbance was
measured at 517 nm using a spectrophotometer. Decrease in ab-
sorbance of the reaction mixture indicates higher free radical
scavenging activity [16].
Superoxide scavenging activity
This method carried out by using Nitro blue tetrazolium (NBT)
reagent, the method is based on generation of super oxide radi-
cal (O2-) by auto oxidation of hydroxylamine hydrochloride in
presence of NBT, during the reaction the NBT is reduced to ni-
trite. In brief, aliquots of 0.1 to 1.0 mL to ascorbic acid solution
were taken in a test tube, to which 1 mL of sodium carbonate, 0.4
mL of NBT and 0.2 mL of EDTA were added and zero minute
reading was taken at 560 nm. The reaction was initiated by the
addition of 0.4 mL of hydroxylamine hydrochloride to the above
solution. Reaction mixture was incubated at 250C for 5 mins;
the reduction of NBT was measured at 560 nm. A parallel con-
trol was also treated in the similar manner. The methanol extract
was treated in the similar manner, absorbance was recorded and
IC50 values was calculated [16].
Evaluation of anticancer activity
Procurement of cell lines
In-vitro anticancer activity for methanol extract was evalu-
ated by MTT assay against MCF-7, HCT-116, HEP-G2, A-549
cells and vero cell lines. The following cells were obtained from
NCCS, Pune and subcultured under suitable conditions [17, 18].
MTT assay
The Cytotoxicity of TCME against MCF-7, HCT-116, HEP-
G2, A-549 and vero cells was determined by the MTT as-
say [17, 18]. Exponentially growing cells were harvested from
25mL flask and a stock cell suspension was prepared. Cells (1
ï¿Ů105/well) were plated in 100ï¡ţl of medium well in 96-well
plates (Costar Corning, Rochester, NY). After 48 hours incuba-
tion the cell reaches the confluence. Then cells were incubated
in the presence of various concentrations of the TCME and stan-
dard drugs in 0. 1% DMSO for 48 h at 37 ï¡řC. The tamox-
ifen was used reference drugs for the breast cancer cell lines
and paclitaxel was used standard drugs for other cell lines. Af-
ter removal of the sample solution and washing with phosphate-
buffered saline (pH7 .4), 20ï¡ţl/well (5 mg/ml) of 0.5% 3-(4,
5-dimethyl-2-thiazolyl)-2, 5-diphenyl-tetrazolium bromide cells
(MTT), phosphate-buffered saline solution was added. After 4h
incubation, 0.04M HCl isopropanol was added. Viable cells
were determined by the absorbance at 450 nm. Measurements
were performed and the concentration required for a 50% inhi-
bition of viability was determined graphically. The absorbance
at 450 nm was measured with a UV- Spectrophotometer using
wells without sample containing cells as blanks. The effect of
the samples on the proliferation of cells was expressed as the %
cell viability, using the following formula:
% cell viability = A450 of treated cells / A450 of control cells
ï¿Ů 100%.
The percentage growth inhibition was calculated using the
following formula.
% growth inhibition =
100−
(
mean abs of individual test grp
Mean abs of control grp
)
x 100
The IC50 value obtained is the concentration of sample re-
quired to inhibit the growth of 50% of viable cell population.
Results & Discussion
Preliminary phytochemical investigation
The percentage yield of the TCME was found to be 8.19 % w/w.
The preliminary phyto-chemical investigation for the methanol
extract of Tephrosia calophylla reveals the presence of poly phe-
nols, flavonoids, tannins, steroids, alkaloids and carbohydrates.
Determination of in-vitro antioxidant activity
DPPH method
In DPPH assay, the methanol extract of Tephrosia calophylla
significantly decreased the absorbance produced by the DPPH
and it was found to possess significant IC50 value which was
comparable to that of standard drug ascorbic acid ( See Table
No.1).
Lipid Peroxidation
The antioxidant property of methanol extract of Tephrosia calo-
phylla and Tephrosia pumila was compared with the standard
Ascorbic acid. In lipid peroxidation assay, the TCME and ascor-
bic acid have significantly inhibited of lipid peroxidation by de-
creasing the absorbance of the supernatant, The IC50 value of
TCME was comparable to that of ascorbic acid (See Table No.1)
Superoxide scavenging activity
In superoxide free radical scavenging activity, the ascorbic acid
TCME has offered good free radical scavenging activity by de-
creasing the absorbance due to NBT and exhibited significant
IC50 value which was comparable to ascorbic acid (See Table
No.1).
Table 1 Effect of methanol extract of Tephrosia calophylla (TCME) on,



















23.51 ± 3.659 53.112±1.03
All the values are expressed as Mean± SEM, n = 6.
Evaluation of in-vitro anticancer activity by MTT assay
Cancer is a dreadful disease and combating this disease is of
great importance to public health [19]. The free radical are ma-
jor cause that damage the genetic material either by inducing
abnormalities in chromosomes (numerical and structural abnor-
malitites) and/or by damaging DNA results in mutation. The
mutations in somatic cells ultimately lead to various cancers
which are the leading causes of death in the human population
and the antioxidants are agents that neutralize free radicals and
proved effective in treating cancers [20, 21]. There is a neces-
sity for search of new compounds with effective cytotoxic ac-
tivity with least side effects as the present treatment availability
is not truly unsatisfactory due to the problem associated with
adverse effects. Medicinal plants have long been used to pre-
vent and treat many diseases, including cancer due to their an-
tioxidant potentials and thus they are good candidates for the
development of anti-cancer drugs. In this regard the study was
performed to evaluate the anticancer potentials of the methanol
extract of Tephrosia calophylla against human normal, breast,
colon, liver and lung cancer cell lines [22, 23].
In the present study, we used 4 types of human cancer cells
for the evaluation of in-vitro cytotoxicity potentials; they are
MCF-7 (breast cancer cell lines), HCT-116 (colon cancer cell
lines), HEP-G2 (liver cancer cell lines) and A-549 (lung cancer
cell lines). All are tested by using trypan blue exclusion method
which is based on decrease in viable tumor cell count and in-
creased nonviable tumor cell count.
MTT assay against MCF-7 cells
Human breast cancer cells are estrogen receptor (ER)-dependent
and carries the wild type tumour suppressor p53 gene [24]. The
Tamoxifen is an estrogen receptor antagonist used to treat the
breast cancer was used in this study as a reference standard drug.
The study revealed that the methanol extract prepared from the
Tephrosia calophylla obtained was effective in attenuating the
viable tumor cell count in dose dependent manner and shown
significant IC50 value which was comparable to results of stan-
dard.
In present study, standard drug Tamoxifen and TCME signifi-
cantly reduced the growth of breast cancer cell lines and the per-
centage of inhibition at was XYZ. In study conducted to deter-
mine the anticancer property of TCME against breast cancer cell
lines, the methanol extract of Tephrosia calophylla has shown
significant cytotoxicity the percentage of inhibition at 500µg/ml
was 68.366. The TCME as it exhibited the significant IC50 val-
ues (Figure No.1 and Figure No.2 and Table No.2)
Table 2 IC50Values of methanol extracts of Tephrosiapumila, Tephrosia







Tamoxifen 25.802 – – – –
Cyclophos-
phamide
– 41.182 33.565 38.479 89.235
TCME 353.773 302.754 263.726 297.75 1540
MTT assay against HCT-116 cells
MTT assay was performed to determine in-vitro anticancer po-
tentials of methanol extract against colon, hepatic and lung alve-
olar cancer cells using Cyclophosphamide as reference stan-
Figure 1 The percentageinhibition of growth of MCF-7 by Tamoxifen
Figure 2 The percentageinhibition of growth of MCF-7 by TCME
dard. We found that the TCME significantly caused cytotoxi-
city against all the three cancer cell lines probably by induc-
ing apoptosis. The IC50 values of TCME against all three, i.e,
HCT-116, HEP-G2 and A-549 were significant and results com-
parable to standard. The standard drug Cyclophosphamide and
TCME significantly reduced the growth of colon cancer cell
lines and the percentage of inhibition at 500µg/ml was 79.773.
The IC50 value of methanol extract of against HCT-116 cell lines
was significant was comparable to standard drug Cyclophos-
phamide (See Figure No.3, 4 and Table No.2).
MTT assay against HEP-G2 cells
In this study, for the determination of anticancer activity of
TCME against human liver cancer cells extract has shown signif-
icant inhibition of the cell growth the percentage of inhibition at
500µg/ml was 87.62. The samples treated with methanol extract
Figure 3 The percentageinhibition of growth of HCT-116 by
Cyclophosphamide
Figure 4 The percentage inhibition of growth of HCT-116 by TCME
of Tephrosia calophylla and standard drug Cyclophosphamide
have shown significant IC50 values which indicates the cytotoxic
potentials of the TCME against liver cancer (See Figure No.5, 6
and Table No.2).
MTT assay against A-549 cells
The methanol extract of Tephrosia calophylla has also shown
significant cytotoxic potentials against lung cancer cells and per-
centage of inhibition of cell growth observed at 500µg/ml was
77.589 and significant IC50 value in the present study. The re-
sults of TCME were comparable to that of Cyclophosphamide
a reference standard used in the study. This also shows useful-
ness of the extract in treating lung cancer (see Figure No.7, 8and
Table No.2).
Figure 5 The percentageinhibition of growth of HEGP-G2 by
Cyclophosphamide
Figure 6 The percentageinhibition of growth of HEGP-G2 by TCME
Figure 7 The percentageinhibition of growth of A-549 by
Cyclophosphamide
Figure 8 The percentageinhibition of growth of A-549 by TCME
MTT assay against Normal human cells (Vero)
In this study the methanol extract of Tephrosia calophylla have
not shown significant cytotoxicity against normal cells and the
maximum inhibition observed at500µg/ml was 16.137. The IC50
value was more than 500µg/ml (see Figure No.9, 10 and Table
No.2). But In MTT assay for the methanol extract against hu-
man normal cells, the treatment with TCME could not show sig-
nificant cytotoxicity as the IC50 value is more than 1000µg/ml.
This indicates the advantage of the extract compared to presently
available anticancer drugs which possess serious adverse effects.
Figure 9 The percentageinhibition of growth of Vero by
Cyclophosphamide
The Tephrosia calophylla was essential component of
Ayurveda a traditional medicinal system of medicine due to
presence of various phyto-constituents for the treatment of vari-
ous health complications such as diabetes mellitus, ulcers, liver
diseases, urinary disorders, cancers and etc. In the present study
the methanol extract was proven for its effective anti-oxidant
potentials which is the important mechanism required for the
Figure 10 The percentageinhibition of growth of Vero by TCME
anticancer activity [25, 26]. The methanol extract also shows the
significant cytotoxicity against various cancer cells while nor-
mal cells were not affected by the extract. But further detailed
study is necessary to correlate the anti-oxidant and cytotoxic
effects of the extract.
Conclusion
The results of the present study suggests that, methanol ex-
tract of Tephrosia calophylla posses in-vitro cytotoxic potentials
against breast cancer, colon cancer, liver cancer and lung cancer
cell lines. Further study is required to explore the in-vivo anti-
cancer property of the plant and also to isolate and evaluate the
specific phyto-constituents from the extract which are responsi-
ble for this beneficial pharmacological properties.
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